Back to Search
JULIE WEBER, MD
MD
Surgery Physician
NPI: 1063674513IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryGENERAL SURGERY
Education
OTHER
Class of 2004
Research & Publications (20)
Ipilimumab: controversies in its development, utility and autoimmune adverse events.
PMID 19198837·Cancer Immunol Immunother·2009
6-review
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
PMID 19536884·Cancer·2009
3-trial
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.
PMID 19671877·Clin Cancer Res·2009
3-trial
Phase I/II study of ipilimumab for patients with metastatic melanoma.
PMID 19018089·J Clin Oncol·2008
3-trial
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010).
PMID 19001147·Oncologist·2008
6-review
Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanoma.
PMID 18997841·J Invest Dermatol·2008
7-preclinical
Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes.
PMID 17096353·Int J Cancer·2007
8-other
Viral fitness: relation to drug resistance mutations and mechanisms involved: nucleoside reverse transcriptase inhibitor mutations.
PMID 19372871·Curr Opin HIV AIDS·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1390 US HIGHWAY 61, STE G1500
FESTUS, MO 63028 - Phone
- (636) 933-1163
Quick Facts
- NPI
- 1063674513
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile